Tevosol

Bridge to Life, a supplier of organ preservation solutions, and Tevosol, a medical device startup, announced their merger to develop and commercialize Tevosol's portable ex-vivo lung perfusion machine and normothermic organ preservation platform. The merger was announced on February 9, 2021.